Flexion Therapeutics Sees Unusually Large Options Volume (FLXN)

Peregrine Capital Management LLC boosted its stake in Flexion Therapeutics by 11.4% in the 4th quarter. The specialty pharmaceutical company reported ($1.38) EPS for the quarter, missing analysts' consensus estimates of ($1.11) by ($0.27). Mccormick & Co Inc now has $14.26B valuation.

The stock decreased 0.10% or $0.06 during the last trading session, reaching $57.44. About 121,986 shares traded. Globalstar, Inc. (NYSEMKT:GSAT) has declined 57.71% since April 18, 2017 and is downtrending. It has underperformed by 17.40% the S&P500.

Flexion Therapeutics, Inc. (FLXN) has year to date performance of 5.27% and weekly performance of 6.63%. (NASDAQ:FLXN). Tower Research (Trc) reported 160 shares. The latest exchange of 0.96 Million shares is below its average trading activity of 892.9 Million shares. About 711,607 shares traded.

Flexion Therapeutics, Inc. (FLXN) stock has performed -0.49% and it registered share value at $26.36 in Wednesday trading session. It has underperformed by 33.01% the S&P500. The United Kingdom-based Jupiter Asset Management Ltd has invested 0.28% in Altria Group, Inc. Its up 1.85, from 1.22 in 2017Q3. The ratio improved, as 98 investment managers started new or increased equity positions, while 82 sold and reduced their holdings in Greif Inc. (NASDAQ:FLXN). Thompson Davis And owns 250 shares or 0.01% of their USA portfolio. Wilbanks Smith And Thomas Asset Mgmt Llc has 8,160 shares. Partnervest Advisory Ltd Liability Co owns 32,993 shares or 0.62% of their U.S. portfolio. Acadian Asset Ltd Liability Corporation has 0% invested in McCormick & Company, Incorporated (NYSE:MKC). Drw Securities Ltd Company holds 0.2% in Altria Group, Inc. (NYSE:T). Carlton Hofferkamp & Jenks Wealth Lc has invested 0.62% in AT&T Inc. Pensionfund Dsm Netherlands holds 0.88% or 87,000 shares in its portfolio. The Company's beta coefficient sits at 0.81. (NYSE:T). Guggenheim Cap Ltd Liability Com holds 0.27% of its portfolio in AT&T Inc. (NASDAQ:STKL). Heartland Advisors accumulated 400,000 shares or 0.2% of the stock.

ANALYSTS VIEWS: The current analyst consensus rating clocked at 1.7 on company shares based on data provided from FINVIZ. It also reduced Vanguard Index Fds (VNQ) stake by 6,325 shares and now owns 53,690 shares. Repligen Corp (NASDAQ:RGEN) was reduced too. The business had revenue of $0.36 million for the quarter, compared to analyst estimates of $1.29 million. (NYSE:T) for 2.94 million shares. $497,500 worth of stock was sold by MANGAN MICHAEL D on Monday, October 30. They issued a "buy" rating and a $42.00 price target for the company. Therefore 75% are positive. McCormick & Company had 45 analyst reports since August 20, 2015 according to SRatingsIntel. Flexion Therapeutics now has a consensus rating of "Buy" and a consensus target price of $99.00. The rating was initiated by UBS with "Neutral" on Wednesday, February 24. The stock has "Buy" rating by Lake Street on Thursday, July 21. The firm earned "Hold" rating on Friday, September 29 by Stifel Nicolaus. Bernstein has "Outperform" rating and $113 target. The firm has "Buy" rating by RBC Capital Markets given on Tuesday, October 24. BidaskClub upgraded Flexion Therapeutics from a "strong sell" rating to a "sell" rating in a research report on Wednesday, March 28th. The firm has "Hold" rating given on Wednesday, August 5 by Jefferies.

Should Value Investors Consider Abbott Laboratories (ABT) And MPLX LP (MPLX)?
Seven research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company's stock. Shareholders of record on Friday, April 13th will be paid a dividend of $0.28 per share. (NYSE:PFE) on Monday, February 26.

New Report: RI Air Quality Is Mixed Bag
That is consistent with a trend toward increasing ozone levels among cities throughout the United States, the report states. Overall, ozone and particle pollution across the USA pales in comparison to other countries in Africa, Europe and Asia.

Evelyn Sharma EXCITED to make Tollywood debut with Prabhas starrer Saaho
Fans have been eagerly waiting to see their favourite Prabhas back on the silver screen, post Baahubali: The Conclusion . The actress, according to a report in Dna will be playing an action-oriented role in the upcoming spy thriller.

Flexion Therapeutics, Inc, a biopharmaceutical company, focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. The company's market cap is $832.30 million. It lead product candidate includes Zilretta, an intra-articular injection for the management of osteoarthritis (OA) pain of the knee. It now has negative earnings.

Investors sentiment increased to 0.93 in 2017 Q4. Its up 1.85, from 1.22 in 2017Q3. AlphaOne also assigned news stories about Flexion Therapeutics an impact score of 63 out of 100, indicating that recent media coverage is somewhat likely to have an effect on the stock's share price in the near term. 31 funds opened positions while 55 raised stakes. Amer Gru has invested 0.56% in Flexion Therapeutics, Inc. Teacher Retirement System Of Texas holds 9,766 shares or 0% of its portfolio.

Flexion Therapeutics (NASDAQ:FLXN) last posted its earnings results on Thursday, March 8th. Moreover, Alps Advsr Inc has 0.01% invested in Flexion Therapeutics, Inc. (NASDAQ:FLXN) for 936,507 shares.

Advent Capital Management increased its stake in Flexion Therapeutics Inc (FLXN) by 1128.45% based on its latest 2017Q4 regulatory filing with the SEC. Oz Mgmt Lp stated it has 0% of its portfolio in Flexion Therapeutics, Inc. Sigma Counselors accumulated 3,452 shares or 0.03% of the stock. Quantbot Technology Ltd Partnership invested in 0% or 189 shares. 188,700 are held by Gam Holding Ag. Washington Tru Company reported 8,186 shares. Finally, Janney Montgomery Scott reiterated a "buy" rating and issued a $30.00 price target on shares of Flexion Therapeutics in a report on Saturday, March 11th. (NASDAQ:FLXN). 165,222 were reported by Schwab Charles Investment. Great West Life Assurance Commerce Can stated it has 2,200 shares. Therefore 100% are positive. The rating was maintained by Northland Capital with "Buy" on Wednesday, October 4. The stock of Altria Group, Inc. The stock has "Buy" rating by Needham on Friday, September 15. The firm earned "Buy" rating on Monday, August 7 by Susquehanna. Wells Fargo set a $39.00 price objective on shares of Flexion Therapeutics and gave the stock a "buy" rating in a research note on Tuesday. The rating was reinitiated by Wells Fargo with "Outperform" on Tuesday, May 3.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Recommended News

We are pleased to provide this opportunity to share information, experiences and observations about what's in the news.
Some of the comments may be reprinted elsewhere in the site or in the newspaper.
Thank you for taking the time to offer your thoughts.